UK News Archive

2020

March

Media Release / Mar 23, 2020

Due to government instruction regarding COVID-19, we are now working remotely.

Read More
Story / Mar 20, 2020

Novartis UK statement on Coronavirus (COVID-19) and our ways of working

Read More
Story / Mar 16, 2020

Novartis UK statement on Coronavirus (COVID-19) and supply chain

Read More

February

Media Release / Feb 11, 2020

UK announced as global centre of major cardiovascular trial as Novartis opens new HQ in White City, London

Read More

January

Media Release / Jan 20, 2020

Novartis receives European licence for Mayzent®▼(siponimod), the first oral treatment for secondary progressive multiple sclerosis (SPMS) with active disease

Read More
Media Release / Jan 13, 2020

Novartis announces intent to collaborate with NHS England to tackle burden of cardiovascular disease in the UK

Read More
2019

November

Story / Nov 19, 2019

New and pioneering health data research hubs have the potential to transform the future of healthcare

Read More
Media Release / Nov 15, 2019

Novartis receives positive CHMP opinion for Mayzent® (siponimod), the first and only oral treatment for secondary progressive multiple sclerosis with active disease

Read More
Media Release / Nov 11, 2019

Novartis’ Kisqali® (ribociclib) in combination with fulvestrant receives recommendation from Scottish Medicines Consortium (SMC) for the treatment of patients with the most common form of advanced breast cancer

Read More

September

Media Release / Sep 25, 2019

Novartis UK response to the NICE Final Appraisal Determination (FAD) for Aimovig® (erenumab) for the prevention of migraine

Read More

Related Links